From December 6–8, the Advanced Technology Research Facility of the Frederick National Laboratory for Cancer Research was abuzz with conversation and collaboration as nearly 450 scientists, academics, and industry partners gathered for the Second RAS Initiative Symposium. Attendees hailed from 14 nations, dozens of institutions, and diverse scientific backgrounds, but they shared a common purpose: to present and discuss their research on RAS genes and cancer.
Our first consideration in every task, large or small, is the safety of our O&M work force and our customers. You, our customer, play an important role in the execution of your work order. The support you provide assists us in understanding the work order requirements, which is the first step in developing a safe plan for accomplishing your request.
Flu season is in full swing, bringing a host of symptoms like congestion, coughs, fever, chills, muscle aches, and fatigue. To help NCI at Frederick employees stay healthy this year, Occupational Health Services (OHS) is offering two types of flu vaccines for free.
The final Holiday Market of 2017 will take place on Tuesday, December 19, in Building 549. The event, which runs from 11:00 am–1:30 pm, will feature nearly two dozen local vendors and artisans. From bags and boards to meats and sweets, the market promises to have something for everyone.
There may be a new, more effective method for treating high-risk neuroblastoma, according to scientists at the Children’s Hospital of Philadelphia and collaborators in the Cancer and Inflammation Program at NCI at Frederick. Together, the groups published a study describing a previously unrecognized protein on neuroblastoma cells, called GPC2, as well as the creation of a novel antibody-drug conjugate, a combination of a human antibody and a naturally occurring anticancer drug, that locates and binds to GPC2 in a highly efficient way.